These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6193566)

  • 1. The effect of prostaglandin I2 and 6a-Carba-PGI2 on the motility of isolated osteoclasts.
    Ali NN; Chambers TJ
    Prostaglandins; 1983 May; 25(5):603-14. PubMed ID: 6193566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ; Ali NN
    J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological control of osteoclastic motility.
    Chambers TJ; Dunn CJ
    Calcif Tissue Int; 1983 Jul; 35(4-5):566-70. PubMed ID: 6311380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostaglandins I2, E1, E2 and dibutyryl cyclic AMP on the cytoplasmic spreading of rat osteoclasts.
    Chambers TJ; Fuller K; Athanasou NA
    Br J Exp Pathol; 1984 Oct; 65(5):557-66. PubMed ID: 6091728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin.
    Chambers TJ; Moore A
    J Clin Endocrinol Metab; 1983 Oct; 57(4):819-24. PubMed ID: 6193136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostacyclin and prostaglandin E1 (PGE1) on bone resorption in the presence and absence of parathyroid hormone.
    Conaway HH; Diez LF; Raisz LG
    Calcif Tissue Int; 1986 Mar; 38(3):130-4. PubMed ID: 3085891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin- and isoproterenol-stimulated cyclic AMP accumulation in rat perinatal lung fibroblasts: effects of developmental age.
    Teixeira FJ; Bevan ML; Olson DM
    Pediatr Res; 1992 Apr; 31(4 Pt 1):344-8. PubMed ID: 1315020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin: effects on cyclic AMP in bone cells.
    Robin JC; Brown MJ; Weinfeld N; Dziak R
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):43-9. PubMed ID: 6276954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin I2 stimulation of granulosa cell cyclic AMP production.
    Goff AK; Zamecnik J; Ali M; Armstrong DT
    Prostaglandins; 1978 May; 15(5):875-9. PubMed ID: 212787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endothelium.
    Adler B; Gimbrone MA; Schafer AI; Handin RI
    Blood; 1981 Sep; 58(3):514-7. PubMed ID: 6167276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.
    Chambers TJ; McSheehy PM; Thomson BM; Fuller K
    Endocrinology; 1985 Jan; 116(1):234-9. PubMed ID: 3880540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin biosynthesis in vascular endothelium is not inhibited by cyclic AMP. Studies with 3-isobutyl-1-methylxanthine and forskolin.
    Brotherton AF; Macfarlane DE; Hoak JC
    Thromb Res; 1982 Dec; 28(5):637-47. PubMed ID: 6188229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cyclic AMP, calcium, and prostaglandins in the induction of osteoclastic bone resorption associated with experimental tooth movement.
    Yamasaki K
    J Dent Res; 1983 Aug; 62(8):877-81. PubMed ID: 6306082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin-like effects of forskolin and choleratoxin on surface area and motility of isolated rabbit osteoclasts.
    Ransjö M; Lerner UH; Heersche JN
    J Bone Miner Res; 1988 Dec; 3(6):611-9. PubMed ID: 3251398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cyclic AMP content of the rat myometrium: desensitization to isoproterenol, PGE2 and prostacyclin.
    Tougui Z; Do Khac L; Harbon S
    Mol Cell Endocrinol; 1980 Oct; 20(1):17-34. PubMed ID: 6254820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.